H.R. 8239 /S. 4661, Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act, FY 2023; provisions related to the regulation of tobacco and electronic nicotine delivery system products, including implementation of enhanced access controls to combat underage access.
Risk-proportionate regulation for electronic nicotine delivery system products to advance tobacco harm reduction for adult smokers and policies to combat underage use.
Issues related to enforcement of illicit tobacco products, including importation of counterfeit products, and unregulated nicotine products.
Issues related to taxation and user fees for tobacco and electronic nicotine delivery system products.
Issues related to regulation of synthetic nicotine products.
Discussions related to implementation of Public Law 111-31, the Family Smoking Prevention and Tobacco Control Act, and PMTA submissions for deemed tobacco products.
H.R. 2125/H.R. 2185/S. 2622, the Quit Because of COVID-19 Act.
H.R. 2786/S. 1314, the Tobacco Tax Equity Act of 2021.
H.R. 3051, the End ENDS Act of 2021.
H.R. 3226, the Accurate Reporting of Smoking Variants Act of 2021.
H.R. 3407/S. 411, the Mothers and Offspring Mortality and Morbidity Awareness Act.
H.R. 4629/S. 2445, the Resources To Prevent Youth Vaping Act.
H.R. 5546/S. 2974, the PROTECT Act.
Duration: January 1, 2019
to
December 31, 2022
General Issues: Budget/Appropriations , Tobacco
Spending: about $780,000 (But it's complicated. Here's why.)
It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.
Agencies lobbied since 2019: U.S. Senate, House of Representatives, Patent & Trademark Office (PTO)
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
4th Quarter, 2022
Oldaker & Willison, LLP (formerly Oldaker Law Group, LLP) terminated an engagement in which they represented JUUL Labs, Inc. on Jan. 5, 2023.
Original Filing: 301425015.xml
Lobbying Issues
H.R. 8239 /S. 4661, Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act, FY 2023; provisions related to the regulation of tobacco and electronic nicotine delivery system products, including implementation of enhanced access controls to combat underage access.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Risk-proportionate regulation for electronic nicotine delivery system products to advance tobacco harm reduction for adult smokers and policies to combat underage use.
Issues related to enforcement of illicit tobacco products, including importation of counterfeit products, and unregulated nicotine products.
Issues related to taxation and user fees for tobacco and electronic nicotine delivery system products.
Issues related to regulation of synthetic nicotine products.
Discussions related to implementation of Public Law 111-31, the Family Smoking Prevention and Tobacco Control Act, and PMTA submissions for deemed tobacco products.
H.R. 2125/H.R. 2185/S. 2622, the Quit Because of COVID-19 Act.
H.R. 2786/S. 1314, the Tobacco Tax Equity Act of 2021.
H.R. 3051, the End ENDS Act of 2021.
H.R. 3226, the Accurate Reporting of Smoking Variants Act of 2021.
H.R. 3407/S. 411, the Mothers and Offspring Mortality and Morbidity Awareness Act.
H.R. 4629/S. 2445, the Resources To Prevent Youth Vaping Act.
H.R. 5546/S. 2974, the PROTECT Act.
Agencies Lobbied
U.S. Senate
3rd Quarter, 2022
In Q3, Oldaker & Willison, LLP (formerly Oldaker Law Group, LLP) lobbied for JUUL Labs, Inc. , earning $36,000. The report was filed on Oct. 19, 2022.
Original Filing: 301412009.xml
Lobbying Issues
H.R. 8239 /S. _____, Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act, FY 2023; provisions related to the regulation of tobacco and electronic nicotine delivery system products, including implementation of enhanced access controls to combat underage access.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Risk-proportionate regulation for electronic nicotine delivery system products to advance tobacco harm reduction for adult smokers and policies to combat underage use.
Issues related to enforcement of illicit tobacco products, including importation of counterfeit products, and unregulated nicotine products.
Issues related to taxation and user fees for tobacco and electronic nicotine delivery system products.
Issues related to regulation of synthetic nicotine products.
Discussions related to implementation of Public Law 111-31, the Family Smoking Prevention and Tobacco Control Act, and PMTA submissions for deemed tobacco products.
H.R. 2125/H.R. 2185/S. 2622, the Quit Because of COVID-19 Act.
H.R. 2786/S. 1314, the Tobacco Tax Equity Act of 2021.
H.R. 3051, the End ENDS Act of 2021.
H.R. 3226, the Accurate Reporting of Smoking Variants Act of 2021.
H.R. 3407/S. 411, the Mothers and Offspring Mortality and Morbidity Awareness Act.
H.R. 4629/S. 2445, the Resources To Prevent Youth Vaping Act.
H.R. 5546/S. 2974, the PROTECT Act.
Agencies Lobbied
U.S. Senate
2nd Quarter, 2022
In Q2, Oldaker & Willison, LLP (formerly Oldaker Law Group, LLP) lobbied for JUUL Labs, Inc. , earning $36,000. The report was filed on July 18, 2022.
Original Filing: 301384009.xml
Lobbying Issues
H.R. 8239 /S. _____, Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act, FY 2023; provisions related to the regulation of tobacco and electronic nicotine delivery system products, including implementation of enhanced access controls to combat underage access.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Risk-proportionate regulation for electronic nicotine delivery system products to advance tobacco harm reduction for adult smokers and policies to combat underage use.
Issues related to enforcement of illicit tobacco products, including importation of counterfeit products, and unregulated nicotine products.
Issues related to taxation and user fees for tobacco and electronic nicotine delivery system products.
Issues related to regulation of synthetic nicotine products.
Discussions related to implementation of Public Law 111-31, the Family Smoking Prevention and Tobacco Control Act, and PMTA submissions for deemed tobacco products.
H.R. 2125/H.R. 2185/S. 2622, the Quit Because of COVID-19 Act.
H.R. 2786/S. 1314, the Tobacco Tax Equity Act of 2021.
H.R. 3051, the End ENDS Act of 2021.
H.R. 3226, the Accurate Reporting of Smoking Variants Act of 2021.
H.R. 3407/S. 411, the Mothers and Offspring Mortality and Morbidity Awareness Act.
H.R. 4629/S. 2445, the Resources To Prevent Youth Vaping Act.
H.R. 5546/S. 2974, the PROTECT Act.
Agencies Lobbied
U.S. Senate
1st Quarter, 2022
In Q1, Oldaker & Willison, LLP (formerly Oldaker Law Group, LLP) lobbied for JUUL Labs, Inc. , earning $36,000. The report was filed on April 20, 2022.
Original Filing: 301370550.xml
Lobbying Issues
Consolidated Appropriations Act, FY 2022; provision related to the regulation of tobacco and electronic nicotine delivery system products, including implementation of enhanced access controls to combat underage access.
Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act, FY 2023; provisions related to the regulation of tobacco and electronic nicotine delivery system products, including implementation of enhanced access controls to combat underage access.
Labor, Health and Human Services, and Related Agencies Appropriations Act, FY 2023; provisions related to the regulation of tobacco and electronic nicotine delivery system products, including implementation of enhanced access controls to combat underage access.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Risk-proportionate regulation for electronic nicotine delivery system products to advance tobacco harm reduction for adult smokers and policies to combat underage use.
Issues related to enforcement of illicit tobacco products, including importation of counterfeit products, and unregulated nicotine products.
Issues related to taxation and user fees for tobacco and electronic nicotine delivery system products.
Discussions related to implementation of Public Law 111-31, the Family Smoking Prevention and Tobacco Control Act, and PMTA submissions for deemed tobacco products.
Agencies Lobbied
U.S. Senate
4th Quarter, 2021
In Q4, Oldaker & Willison, LLP (formerly Oldaker Law Group, LLP) lobbied for JUUL Labs, Inc. , earning $36,000. The report was filed on Jan. 20, 2022.
Original Filing: 301332799.xml
Lobbying Issues
H.R. ___/S.___, Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act, FY 2022; provisions related to the regulation of tobacco and electronic nicotine delivery system products, including implementation of enhanced access controls to combat underage access.
H.R. ___/S.___, Labor, Health and Human Services, and Related Agencies Appropriations Act, FY 2022; provisions related to the regulation of tobacco and electronic nicotine delivery system products, including implementation of enhanced access controls to combat underage access.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Risk-proportionate regulation for electronic nicotine delivery system products to advance tobacco harm reduction for adult smokers and policies to combat underage use.
Issues related to enforcement of illicit tobacco products, including importation of counterfeit products, and unregulated nicotine products.
Issues related to taxation and user fees for tobacco and electronic nicotine delivery system products.
Discussions related to implementation of Public Law 111-31, the Family Smoking Prevention and Tobacco Control Act, and PMTA submissions for deemed tobacco products.
Agencies Lobbied
U.S. Senate
3rd Quarter, 2021
In Q3, Oldaker & Willison, LLP (formerly Oldaker Law Group, LLP) lobbied for JUUL Labs, Inc. , earning $36,000. The report was filed on Oct. 19, 2021.
Original Filing: 301305646.xml
Lobbying Issues
H.R. ___/S.___, Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act, FY 2022; provisions related to the regulation of tobacco and electronic nicotine delivery system products, including implementation of enhanced access controls to combat underage access.
H.R. ___/S.___, Labor, Health and Human Services, and Related Agencies Appropriations Act, FY 2022; provisions related to the regulation of tobacco and electronic nicotine delivery system products, including implementation of enhanced access controls to combat underage access.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Risk-proportionate regulation for electronic nicotine delivery system products to advance tobacco harm reduction for adult smokers and policies to combat underage use.
Issues related to enforcement of illicit tobacco products, including importation of counterfeit products, and unregulated nicotine products.
Issues related to taxation and user fees for tobacco and electronic nicotine delivery system products.
Discussions related to implementation of Public Law 111-31, the Family Smoking Prevention and Tobacco Control Act, and PMTA submissions for deemed tobacco products.
Agencies Lobbied
U.S. Senate
2nd Quarter, 2021
In Q2, Oldaker & Willison, LLP (formerly Oldaker Law Group, LLP) lobbied for JUUL Labs, Inc. , earning $36,000. The report was filed on July 20, 2021.
Original Filing: 301285404.xml
Lobbying Issues
H.R. ___/S.___, Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act, FY 2022; provisions related to the regulation of tobacco and electronic nicotine delivery system products, including implementation of enhanced access controls to combat underage access.
H.R. ___/S.___, Labor, Health and Human Services, and Related Agencies Appropriations Act, FY 2022; provisions related to the regulation of tobacco and electronic nicotine delivery system products, including implementation of enhanced access controls to combat underage access.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Risk-proportionate regulation for electronic nicotine delivery system products to advance tobacco harm reduction for adult smokers and policies to combat underage use.
Issues related to enforcement of illicit tobacco products, including importation of counterfeit products, and unregulated nicotine products.
Issues related to taxation and user fees for tobacco and electronic nicotine delivery system products.
Discussions related to implementation of Public Law 111-31, the Family Smoking Prevention and Tobacco Control Act, and PMTA submissions for deemed tobacco products.
Agencies Lobbied
U.S. Senate
1st Quarter, 2021
Oldaker & Willison, LLP (formerly Oldaker Law Group, LLP) amended a lobbying report for representation of JUUL Labs, Inc. in Q12021 on April 22, 2021.
Original Filing: 301269025.xml
Lobbying Issues
H.R. ___/S.___, Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act, FY 2022; provisions related to the regulation of tobacco and electronic nicotine delivery system products, including implementation of enhanced access controls to combat underage access.
H.R. ___/S.___, Labor, Health and Human Services, and Related Agencies Appropriations Act, FY 2022; provisions related to the regulation of tobacco and electronic nicotine delivery system products, including implementation of enhanced access controls to combat underage access.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Risk-proportionate regulation for electronic nicotine delivery system products to advance tobacco harm reduction for adult smokers and policies to combat underage use.
Issues related to enforcement of illicit tobacco products, including importation of counterfeit products, and unregulated nicotine products.
Issues related to taxation and user fees for tobacco and electronic nicotine delivery system products.
Discussions related to implementation of Public Law 111-31, the Family Smoking Prevention and Tobacco Control Act, and PMTA submissions for deemed tobacco products.
Agencies Lobbied
U.S. Senate
1st Quarter, 2021
Oldaker & Willison, LLP (formerly Oldaker Law Group, LLP) amended a lobbying report for representation of JUUL Labs, Inc. in Q12021 on April 19, 2021.
Original Filing: 301256620.xml
Lobbying Issues
H.R. ___/S.___, Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act, FY 2022; provisions related to the regulation of tobacco and electronic nicotine delivery system products, including implementation of enhanced access controls to combat underage access.
H.R. ___/S.___, Labor, Health and Human Services, and Related Agencies Appropriations Act, FY 2022; provisions related to the regulation of tobacco and electronic nicotine delivery system products, including implementation of enhanced access controls to combat underage access.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Risk-proportionate regulation for electronic nicotine delivery system products to advance tobacco harm reduction for adult smokers and policies to combat underage use.
Issues related to enforcement of illicit tobacco products, including importation of counterfeit products, and unregulated nicotine products.
Issues related to taxation and user fees for tobacco and electronic nicotine delivery system products.
Discussions related to implementation of Public Law 111-31, the Family Smoking Prevention and Tobacco Control Act, and PMTA submissions for deemed tobacco products.
Agencies Lobbied
U.S. Senate
1st Quarter, 2021
In Q1, Oldaker & Willison, LLP (formerly Oldaker Law Group, LLP) lobbied for JUUL Labs, Inc. , earning $48,000. The report was filed on April 16, 2021.
Original Filing: 301254451.xml
Lobbying Issues
H.R. 7610/S.___, Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act, FY 2021; provisions related to the regulation of tobacco and electronic nicotine delivery system products, including implementation of a national track and trace system to ensure enforcement against illicit trade;
H.R. ____/S____,Labor,Health and Human Services, and Related Agencies Appropriations Act, FY2021; discussions related to the correlation between vitamin E acetate and the EVALI cases.
S. 2517, Tobacco Tax Equity Act of 2019;
S. 2519, Prohibiting Non-tobacco E-cigarette Flavors;
S. 2536, E-Cigarette Device Standards Act of 2019
Agencies Lobbied
U.S. Senate
4th Quarter, 2020
Oldaker & Willison, LLP (formerly Oldaker Law Group, LLP) amended a lobbying report for representation of JUUL Labs, Inc. in Q42020 on April 22, 2021.
Original Filing: 301269027.xml
Lobbying Issues
H.R. 7610/S.___, Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act, FY 2021; provisions related to the regulation of tobacco and electronic nicotine delivery system products, including implementation of a national track and trace system to ensure enforcement against illicit trade;
H.R. ____/S____,Labor,Health and Human Services, and Related Agencies Appropriations Act, FY2021; discussions related to the correlation between vitamin E acetate and the EVALI cases.
S. 2517, Tobacco Tax Equity Act of 2019;
S. 2519, Prohibiting Non-tobacco E-cigarette Flavors;
S. 2536, E-Cigarette Device Standards Act of 2019
Agencies Lobbied
U.S. Senate
4th Quarter, 2020
In Q4, Oldaker & Willison, LLP (formerly Oldaker Law Group, LLP) lobbied for JUUL Labs, Inc. , earning $40,000. The report was filed on Jan. 21, 2021.
Original Filing: 301243783.xml
Lobbying Issues
H.R. 7610/S.___, Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act, FY 2021; provisions related to the regulation of tobacco and electronic nicotine delivery system products, including implementation of a national track and trace system to ensure enforcement against illicit trade;
H.R. ____/S____,Labor,Health and Human Services, and Related Agencies Appropriations Act, FY2021; discussions related to the correlation between vitamin E acetate and the EVALI cases.
S. 2517, Tobacco Tax Equity Act of 2019;
S. 2519, Prohibiting Non-tobacco E-cigarette Flavors;
S. 2536, E-Cigarette Device Standards Act of 2019
Agencies Lobbied
U.S. Senate
3rd Quarter, 2020
In Q3, Oldaker & Willison, LLP (formerly Oldaker Law Group, LLP) lobbied for JUUL Labs, Inc. , earning $40,000. The report was filed on Oct. 20, 2020.
Original Filing: 301224307.xml
Lobbying Issues
H.R. 7610/S.___, Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act, FY 2021; provisions related to the regulation of tobacco and electronic nicotine delivery system products, including implementation of a national track and trace system to ensure enforcement against illicit trade;
H.R. ____/S____,Labor,Health and Human Services, and Related Agencies Appropriations Act, FY2021; discussions related to the correlation between vitamin E acetate and the EVALI cases.
S. 2517, Tobacco Tax Equity Act of 2019;
S. 2519, Prohibiting Non-tobacco E-cigarette Flavors;
S. 2536, E-Cigarette Device Standards Act of 2019
Agencies Lobbied
U.S. Senate
2nd Quarter, 2020
Oldaker & Willison, LLP (formerly Oldaker Law Group, LLP) amended a lobbying report for representation of JUUL Labs, Inc. in Q22020 on July 22, 2020.
Original Filing: 301203430.xml
Lobbying Issues
H.R. 7610/S.___, Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act, FY 2021; provisions related to the regulation of tobacco and electronic nicotine delivery system products, including implementation of a national track and trace system to ensure enforcement against illicit trade;
H.R. ____/S____,Labor,Health and Human Services, and Related Agencies Appropriations Act, FY2021; discussions related to the correlation between vitamin E acetate and the EVALI cases.
S. 2517, Tobacco Tax Equity Act of 2019;
S. 2519, Prohibiting Non-tobacco E-cigarette Flavors;
S. 2536, E-Cigarette Device Standards Act of 2019
Agencies Lobbied
U.S. Senate
2nd Quarter, 2020
In Q2, Oldaker & Willison, LLP (formerly Oldaker Law Group, LLP) lobbied for JUUL Labs, Inc. , earning $60,000. The report was filed on July 20, 2020.
Original Filing: 301199908.xml
Lobbying Issues
H.R. 7610/S.___, Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act, FY 2021; provisions related to the regulation of tobacco and electronic nicotine delivery system products, including implementation of a national track and trace system to ensure enforcement against illicit trade;
H.R. ____/S____,Labor,Health and Human Services, and Related Agencies Appropriations Act, FY2021; discussions related to the correlation between vitamin E acetate and the EVALI cases.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Regulation of Electronic Nicotine Delivery System products as a less harmful alternative for adult smokers
Issues related to enforcement of illicit tobacco products, including importation of counterfeit products
Issues related to taxation and user fees for tobacco products
H.R. 293, Youth Vaping Prevention Act of 2019;
H.R. 1498/S, 655, SAFE Kids Act;
H.R. 1642/S. 1965 Combating the Ilicit Trade in Tobacco Products Act;
H.R. 1897/S. 916 MOMMA's Act; provisions to taxation of tobacco products
H.R. 2084, SCOTT Act of 2019
H.R. 2111/ S. 1048, PROTECT Act
H.R. 2339/S.3174, Reversing the Youth Tobacco Epidemic Act;
H.R. 4425, Quell Underage Inhaling of Toxic Substances Act of 2019;
H.R. 3942/S. 1253, Preventing Online Sales of E-Cigarettes to Children Act;
H.R. 5721/S. 3223, Resources to Prevent Youth Vaping Act;
S. 616, E-cigarette Youth Protection Act;
H.R. 6637, Health Equity and Accountability Act of 2020; provisions related to taxation of tobacco products;
S. 2517, Tobacco Tax Equity Act of 2019;
S. 2519, Prohibiting Non-tobacco E-cigarette Flavors;
S. 2536, E-Cigarette Device Standards Act of 2019
Agencies Lobbied
U.S. Senate
1st Quarter, 2020
In Q1, Oldaker & Willison, LLP (formerly Oldaker Law Group, LLP) lobbied for JUUL Labs, Inc. , earning $60,000. The report was filed on April 17, 2020.
Original Filing: 301169619.xml
Lobbying Issues
Issues pertaining to e-cigarette and vaporizer products
Counterfeit product detection and prevention
Agencies Lobbied
U.S. Senate
4th Quarter, 2019
In Q4, Oldaker & Willison, LLP (formerly Oldaker Law Group, LLP) lobbied for JUUL Labs, Inc. , earning $80,000. The report was filed on Jan. 16, 2020.
Original Filing: 301107530.xml
Lobbying Issues
Issues pertaining to e-cigarette and vaporizer products
Counterfeit product detection and prevention
Agencies Lobbied
U.S. Senate
3rd Quarter, 2019
Oldaker & Willison, LLP (formerly Oldaker Law Group, LLP) amended a lobbying report for representation of JUUL Labs, Inc. in Q32019 on Oct. 21, 2019.
Original Filing: 301076020.xml
Lobbying Issues
Issues pertaining to e-cigarette and vaporizer products
Counterfeit product detection and prevention
Agencies Lobbied
U.S. Senate
3rd Quarter, 2019
In Q3, Oldaker & Willison, LLP (formerly Oldaker Law Group, LLP) lobbied for JUUL Labs, Inc. , earning $80,000. The report was filed on Oct. 18, 2019.
Original Filing: 301070902.xml
Lobbying Issues
Issues pertaining to e-cigarette and vaporizer products
Counterfeit product detection and prevention
Agencies Lobbied
U.S. Senate
2nd Quarter, 2019
In Q2, Oldaker & Willison, LLP (formerly Oldaker Law Group, LLP) lobbied for JUUL Labs, Inc. , earning $60,000. The report was filed on July 16, 2019.
Original Filing: 301046842.xml
Lobbying Issues
Issues pertaining to e-cigarette and vaporizer products
Counterfeit product detection and prevention
Agencies Lobbied
U.S. Senate
1st Quarter, 2019
In Q1, Oldaker & Willison, LLP (formerly Oldaker Law Group, LLP) lobbied for JUUL Labs, Inc. , earning $60,000. The report was filed on April 18, 2019.
Original Filing: 301028620.xml
Lobbying Issues
Issues pertaining to e-cigarette and vaporizer products
Agencies Lobbied
U.S. Senate
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate
Searching...